BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 20183130)

  • 21. Enhanced biofilm formation and 3-chlorobenzoate degrading activity by the bacterial consortium of Burkholderia sp. NK8 and Pseudomonas aeruginosa PAO1.
    Yoshida S; Ogawa N; Fujii T; Tsushima S
    J Appl Microbiol; 2009 Mar; 106(3):790-800. PubMed ID: 19191976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of a cation channel blocker (furosemide) on Pseudomonas aeruginosa PAO1 biofilm architecture.
    Cross JL; Ramadan HH; Thomas JG
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):21-6. PubMed ID: 17599559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms.
    Alkawash MA; Soothill JS; Schiller NL
    APMIS; 2006 Feb; 114(2):131-8. PubMed ID: 16519750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of bacterial biofilms with marine alkaloid derivatives.
    Huigens RW; Ma L; Gambino C; Moeller PD; Basso A; Cavanagh J; Wozniak DJ; Melander C
    Mol Biosyst; 2008 Jun; 4(6):614-21. PubMed ID: 18493660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring of microbial adhesion and biofilm growth using electrochemical impedancemetry.
    Dheilly A; Linossier I; Darchen A; Hadjiev D; Corbel C; Alonso V
    Appl Microbiol Biotechnol; 2008 May; 79(1):157-64. PubMed ID: 18330564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylcholine impairs susceptibility to biofilm formation of hydrogel contact lenses.
    Selan L; Palma S; Scoarughi GL; Papa R; Veeh R; Di Clemente D; Artini M
    Am J Ophthalmol; 2009 Jan; 147(1):134-9. PubMed ID: 18790470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
    Kotulová D; Slobodníková L
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marine bacterial isolates inhibit biofilm formation and disrupt mature biofilms of Pseudomonas aeruginosa PAO1.
    Nithya C; Begum MF; Pandian SK
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):341-58. PubMed ID: 20665017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staphylococcus aureus biofilm formation and tolerance to antibiotics in response to oscillatory shear stresses of physiological levels.
    Kostenko V; Salek MM; Sattari P; Martinuzzi RJ
    FEMS Immunol Med Microbiol; 2010 Aug; 59(3):421-31. PubMed ID: 20528928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of erythromycin and fosfomycin on Pseudomonas aeruginosa biofilm in vitro].
    Xu Z; Liu F; Wang X
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):342-4. PubMed ID: 11802985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Model system studies of the influence of bacterial biofilm formation on mineral surface reactivity.
    Brydie JR; Wogelius RA; Boult S; Merrifield CM; Vaughan DJ
    Biofouling; 2009; 25(5):463-72. PubMed ID: 19353390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Confocal Raman microspectroscopy as a tool for studying the chemical heterogeneities of biofilms in situ.
    Sandt C; Smith-Palmer T; Pink J; Brennan L; Pink D
    J Appl Microbiol; 2007 Nov; 103(5):1808-20. PubMed ID: 17953591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biofilm-detached cells, a transition from a sessile to a planktonic phenotype: a comparative study of adhesion and physiological characteristics in Pseudomonas aeruginosa.
    Rollet C; Gal L; Guzzo J
    FEMS Microbiol Lett; 2009 Jan; 290(2):135-42. PubMed ID: 19054076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis.
    Kalishwaralal K; BarathManiKanth S; Pandian SR; Deepak V; Gurunathan S
    Colloids Surf B Biointerfaces; 2010 Sep; 79(2):340-4. PubMed ID: 20493674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms.
    Haagensen J; Verotta D; Huang L; Engel J; Spormann AM; Yang K
    J Antimicrob Chemother; 2017 Dec; 72(12):3357-3365. PubMed ID: 28961810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substrata effects on bacterial biofilm development in a subsurface flow dairy waste treatment wetland.
    Silyn-Roberts G; Lewis G
    Water Sci Technol; 2003; 48(8):261-9. PubMed ID: 14682595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance of dormant and active cells in Pseudomonas aeruginosa PA01 biofilm to antimicrobial agents.
    Kim J; Hahn JS; Franklin MJ; Stewart PS; Yoon J
    J Antimicrob Chemother; 2009 Jan; 63(1):129-35. PubMed ID: 19001451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial and anti-biofilm effect of a novel BODIPY photosensitizer against Pseudomonas aeruginosa PAO1.
    Orlandi VT; Rybtke M; Caruso E; Banfi S; Tolker-Nielsen T; Barbieri P
    Biofouling; 2014 Sep; 30(8):883-91. PubMed ID: 25184429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applying the digital image correlation method to estimate the mechanical properties of bacterial biofilms subjected to a wall shear stress.
    Mathias JD; Stoodley P
    Biofouling; 2009 Nov; 25(8):695-703. PubMed ID: 20183128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azithromycin retards Pseudomonas aeruginosa biofilm formation.
    Gillis RJ; Iglewski BH
    J Clin Microbiol; 2004 Dec; 42(12):5842-5. PubMed ID: 15583321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.